scholarly article | Q13442814 |
P50 | author | Céline Moutou | Q96155904 |
P2093 | author name string | Joanne Traeger-Synodinos | |
Martine De Rycke | |||
Joep Geraedts | |||
Katerina Vesela | |||
Joyce Harper | |||
Veerle Goossens | |||
Francesco Fiorentino | |||
Gary Harton | |||
Edith Coonen | |||
Pam Renwick | |||
Sioban Sengupta | |||
Tugce Pehlivan Budak | |||
P2860 | cites work | High resolution array-CGH analysis of single cells | Q33267061 |
ESHRE PGD Consortium data collection IX: cycles from January to December 2006 with pregnancy follow-up to October 2007. | Q33436560 | ||
Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. | Q34357019 | ||
What next for preimplantation genetic screening? High mitotic chromosome instability rate provides the biological basis for the low success rate | Q37390000 | ||
Preimplantation genetic screening to improve in vitro fertilization pregnancy rates: a prospective randomized controlled trial | Q40146578 | ||
Preimplantation genetic screening outcomes are associated with culture conditions | Q43422450 | ||
A prospective randomized controlled trial of preimplantation genetic screening in the "good prognosis" patient | Q48738473 | ||
Preimplantation aneuploidy testing for infertile patients of advanced maternal age: a randomized prospective trial | Q48741471 | ||
Assessment of numeric abnormalities of X, Y, 18, and 16 chromosomes in preimplantation human embryos before transfer. | Q50762701 | ||
Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. | Q51678170 | ||
Chromosome instability is common in human cleavage-stage embryos. | Q53398239 | ||
What next for preimplantation genetic screening (PGS)? Experience with blastocyst biopsy and testing for aneuploidy. | Q53472614 | ||
Removal of 2 cells from cleavage stage embryos is likely to reduce the efficacy of chromosomal tests that are used to enhance implantation rates | Q57779232 | ||
Will preimplantation genetic diagnosis assist patients with a poor prognosis to achieve pregnancy? | Q57779472 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 821-823 | |
P577 | publication date | 2010-02-02 | |
P1433 | published in | Human Reproduction | Q5937357 |
P1476 | title | What next for preimplantation genetic screening (PGS)? A position statement from the ESHRE PGD Consortium Steering Committee | |
P478 | volume | 25 |
Q38031577 | A methodological overview on molecular preimplantation genetic diagnosis and screening: a genomic future? |
Q36434649 | A review of, and commentary on, the ongoing second clinical introduction of preimplantation genetic screening (PGS) to routine IVF practice |
Q50913286 | Adjuncts in the IVF laboratory: where is the evidence for 'add-on' interventions? |
Q35357388 | Application of next-generation sequencing technology for comprehensive aneuploidy screening of blastocysts in clinical preimplantation genetic screening cycles |
Q34944766 | Blood pressure and anthropometrics of 4-y-old children born after preimplantation genetic screening: follow-up of a unique, moderately sized, randomized controlled trial |
Q56973422 | Current issues in medically assisted reproduction and genetics in Europe: research, clinical practice, ethics, legal issues and policy |
Q95826815 | Current issues in medically assisted reproduction and genetics in Europe: research, clinical practice, ethics, legal issues and policy. European Society of Human Genetics and European Society of Human Reproduction and Embryology |
Q37828026 | Delayed childbearing: effects on fertility and the outcome of pregnancy |
Q37059959 | Discrepant diagnosis rate of array comparative genomic hybridization in thawed euploid blastocysts |
Q53289190 | Does additional hybridization also improve preimplantation genetic screening results? |
Q28286723 | Dynamics and ethics of comprehensive preimplantation genetic testing: a review of the challenges |
Q33683144 | ESHRE PGD Consortium data collection X: cycles from January to December 2007 with pregnancy follow-up to October 2008. |
Q34263818 | ESHRE PGD Consortium data collection XI: cycles from January to December 2008 with pregnancy follow-up to October 2009. |
Q30970981 | ESHRE PGD Consortium data collection XIII: cycles from January to December 2010 with pregnancy follow-up to October 2011. |
Q47622050 | ESHRE PGD Consortium data collection XIV-XV: cycles from January 2011 to December 2012 with pregnancy follow-up to October 2013. |
Q85239152 | ESHRE PGD Consortium/Embryology Special Interest Group--best practice guidelines for polar body and embryo biopsy for preimplantation genetic diagnosis/screening (PGD/PGS) |
Q38590592 | Elective Single Embryo Transfer: an update to UK Best Practice Guidelines |
Q47724353 | Genetic diseases and aneuploidies can be detected with a single blastocyst biopsy: a successful clinical approach |
Q48493269 | Genetics and bioethics: how our thinking has changed since 1969. |
Q38575047 | How should we choose the 'best' embryo? A commentary on behalf of the British Fertility Society and the Association of Clinical Embryologists |
Q39274880 | Karyomapping and how is it improving preimplantation genetics? |
Q36390581 | Lessons from elective in vitro fertilization (IVF) in, principally, non-infertile women |
Q26822576 | Metabolomic assessment of embryo viability |
Q36035686 | Multiple meiotic errors caused by predivision of chromatids in women of advanced maternal age undergoing in vitro fertilisation |
Q35887436 | New array approaches to explore single cells genomes |
Q36342048 | New protocol based on massive parallel sequencing for aneuploidy screening of preimplantation human embryos. |
Q34113055 | OMICS: Current and future perspectives in reproductive medicine and technology |
Q38282802 | Polar bodies in assisted reproductive technology: current progress and future perspectives |
Q35389273 | Polar body array CGH for prediction of the status of the corresponding oocyte. Part I: clinical results |
Q90258032 | Prediction of the in vitro developmental competence of early-cleavage-stage human embryos with time-lapse imaging and oxygen consumption rate measurement |
Q44400550 | Preimplantation diagnosis--PID: preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS) |
Q37691155 | Preimplantation genetic diagnosis guided by single-cell genomics |
Q47120861 | Preimplantation genetic diagnosis: an update on current technologies and ethical considerations |
Q34199663 | Preimplantation genetic diagnosis: state of the art 2011. |
Q38671062 | Preimplantation genetic screening |
Q37300095 | Preimplantation genetic screening (PGS) with Comparative genomic hybridization (CGH) following day 3 single cell blastomere biopsy markedly improves IVF outcomes while lowering multiple pregnancies and miscarriages. |
Q24244735 | Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection |
Q36068679 | Preimplantation genetic screening for all 24 chromosomes by microarray comparative genomic hybridization significantly increases implantation rates and clinical pregnancy rates in patients undergoing in vitro fertilization with poor prognosis |
Q34199329 | Preimplantation genetic screening: does it help or hinder IVF treatment and what is the role of the embryo? |
Q38864772 | Preimplantation genetic testing for aneuploidy: what technology should you use and what are the differences? |
Q46297164 | Production of offspring after sperm chromosome screening: an experiment using the mouse model |
Q34334104 | Singling out genetic disorders and disease |
Q34724819 | The 'thousand-dollar genome': an ethical exploration |
Q33592827 | The accumulation of vitrified oocytes is a strategy to increase the number of euploid available blastocysts for transfer after preimplantation genetic testing |
Q36758994 | The impact of patient preselection on reported IVF outcomes |
Q38132735 | Twenty years of Cochrane reviews in menstrual disorders and subfertility. |
Q47311284 | Vorsprung durch Technik: On biotechnology, bioethics, and its beneficiaries |
Q41606774 | When and how should new technology be introduced into the IVF laboratory? |
Q30391597 | Whole-genome sequencing in health care. Recommendations of the European Society of Human Genetics |
Search more.